MedPath

Precose

PRECOSE ( acarbose tablets)

Approved
Approval ID

e2158832-ad0b-4b9c-bbf0-1608a177bf85

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acarbose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5831
Application NumberNDA020482
Product Classification
M
Marketing Category
C73594
G
Generic Name
Acarbose
Product Specifications
Route of AdministrationORAL
Effective DateMay 23, 2012
FDA Product Classification

INGREDIENTS (5)

ACARBOSEActive
Quantity: 25 mg in 1 1
Code: T58MSI464G
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Precose - FDA Drug Approval Details